Literature DB >> 7589040

Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris.

K Ogino1, S Osaki, N Noguchi, H Kitamura, H Omodani, M Kato, I Hisatome, T Matsumoto, T Kinugawa, H Miyakoda.   

Abstract

To elucidate the effect of Nicorandil on myocardial energy metabolism and myocardial sympathetic activity, we administered Nicorandil orally to eight patients with angina pectoris prior to exercise testing. Arterial and coronary sinus levels of lactate, ammonia, hypoxanthine (HX), adrenaline and noradrenaline were measured during exercise in order to determine the irrespective myocardial extraction ratios (MER). Compared to placebo, Nicorandil increased the time to development of significant ST depression (322 vs 390 s) while decreasing the maximum amplitude of ST depression (0.244 vs 0.216 mV). Heart rate, systolic blood pressure, and the rate pressure product during exercise were not significantly affected. The MER of lactate, measured during exercise, was significantly higher after Nicorandil than placebo (13.6 vs 27.9). Similarly, the MERs of ammonia and HX were significantly higher after Nicorandil (-46.0 vs 7.4% and -47.0 vs 9.9% respectively). Nicorandil, had no apparent effect on myocardial sympathetic activity as the MERs of adrenaline and noradrenaline were essentially unaffected. We conclude that Nicorandil decreased myocardial ischaemia and suppressed myocardial accelerated purine metabolism (a marker of cellular energy metabolism) during exercise in patients with angina pectoris. This effect appears not to be related to myocardial sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589040     DOI: 10.1007/BF00198297

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine, and propranolol.

Authors:  K Kobayashi; T Hakuta
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

2.  Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure.

Authors:  B Andersson; C Blomström-Lundqvist; T Hedner; F Waagstein
Journal:  J Am Coll Cardiol       Date:  1991-10       Impact factor: 24.094

3.  Excess purine degradation in muscle of chronic hemodialysis patients.

Authors:  H Kosaka; I Hisatome; K Ogino; Y Tanaka; S Osaki; H Kitamura; H Omodani; T Matsumoto; H Miyakoda; H Kotake
Journal:  Nephron       Date:  1993       Impact factor: 2.847

4.  Adenosine formation and myocardial energy status during graded hypoxia.

Authors:  M X He; M W Gorman; G D Romig; H V Sparks
Journal:  J Mol Cell Cardiol       Date:  1992-01       Impact factor: 5.000

5.  Adenine nucleotide catabolism and adenosine formation in isolated human cardiomyocytes.

Authors:  R T Smolenski; A Suitters; M H Yacoub
Journal:  J Mol Cell Cardiol       Date:  1992-01       Impact factor: 5.000

6.  Suppression of sympathetic nervous system activity by nicorandil during exercise.

Authors:  K Ogino; T Kinugawa; N Noguchi; H Kitamura; T Matsumoto; H Miyakoda; H Kotake; H Mashiba
Journal:  Gen Pharmacol       Date:  1992-05

7.  Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.

Authors:  H Nakaya; A Schwartz; R W Millard
Journal:  Circ Res       Date:  1983-03       Impact factor: 17.367

8.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

9.  Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure.

Authors:  K Swedberg; C Viquerat; J L Rouleau; M Roizen; B Atherton; W W Parmley; K Chatterjee
Journal:  Am J Cardiol       Date:  1984-10-01       Impact factor: 2.778

10.  Plasma hypoxanthine and exercise.

Authors:  L H Ketai; R H Simon; J W Kreit; C M Grum
Journal:  Am Rev Respir Dis       Date:  1987-07
View more
  2 in total

Review 1.  Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.

Authors:  A Markham; G L Plosker; K L Goa
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 2.  Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.

Authors:  Dene Simpson; Keri Wellington
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.